A PRACTICAL APPROACH TO CHRONIC HEPATITIS B TREATMENT

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

JAMALI RAIKA; EBRAHIMI DARYANI NASER

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Feyz Medical Sciences Journal Year:2010 | Volume:13 | Issue:4 (SERIAL 52) Page(s): 332-344

Download Full-Text

Persian Verion

View:

757

Download:

Cites:

Information Journal Paper

Title

A PRACTICAL APPROACH TO CHRONIC HEPATITIS B TREATMENT

Author(s)

JAMALI RAIKA | EBRAHIMI DARYANI NASER | Issue Writer Certificate

Keywords

CLINICAL PROTOCOLSQ2

INTERFERONQ3

ANTIVIRAL AGENTSQ3

CHRONIC HEPATITIS BQ3

Abstract

Background: CHRONIC HEPATITIS B is among the prevalent causes of chronic hepatitis and cirrhosis. The aim of this article is to discuss the indications for treatment, available drugs, and identify drug resistance or intolerance and primary treatment failure in CHRONIC HEPATITIS B.Materials and Methods: A summary of epidemiology, natural course and treatment options of CHRONIC HEPATITIS B is presented in this paper according to AASLD practical guidelines for treatment of hepatitis B (2009). On the basis of serum HBV DNA, alanin aminotransferase and HBe Ag level as well as the liver histological findings the natural course of CHRONIC HEPATITIS B is divided into four phases: immune tolerance, immune clearance, inactive carrier state and relapse. These phases indicate the patient's immune system activation against the virus and the leading histological liver damage.Results: Patients in immune tolerance and inactive carrier state phases do not need treatment and should only be followed up; while those in immune clearance and relapse phases do need treatment. Selection of PEG IFN or nucleoside analogues should be based on the presence of cirrhosis, viral load and genotype, drug resistance and also the patient's preference. Drug intolerance or resistance can lead to relapse and drug should be stopped or changed in these occasions.Conclusion: Due to the rapid increase of information about CHRONIC HEPATITIS B treatment and generation of new antiviral medicines, the guidelines for treatment are changing rapidly.Appropriate early treatment decreases mortality and morbidity rate caused by liver disease.

Cites

No record.

References

No record.

Cite

APA: Copy

JAMALI, RAIKA, & EBRAHIMI DARYANI, NASER. (2010). A PRACTICAL APPROACH TO CHRONIC HEPATITIS B TREATMENT. FEYZ, 13(4 (SERIAL 52)), 332-344. SID. https://sid.ir/paper/40563/en

Vancouver: Copy

JAMALI RAIKA, EBRAHIMI DARYANI NASER. A PRACTICAL APPROACH TO CHRONIC HEPATITIS B TREATMENT. FEYZ[Internet]. 2010;13(4 (SERIAL 52)):332-344. Available from: https://sid.ir/paper/40563/en

IEEE: Copy

RAIKA JAMALI, and NASER EBRAHIMI DARYANI, “A PRACTICAL APPROACH TO CHRONIC HEPATITIS B TREATMENT,” FEYZ, vol. 13, no. 4 (SERIAL 52), pp. 332–344, 2010, [Online]. Available: https://sid.ir/paper/40563/en

Related Journal Papers